1998
DOI: 10.1016/s0196-0644(98)70229-x
|View full text |Cite
|
Sign up to set email alerts
|

Management of Anaphylactoid Reactions to Intravenous N-Acetylcysteine

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
68
0
1

Year Published

2000
2000
2023
2023

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 126 publications
(72 citation statements)
references
References 23 publications
3
68
0
1
Order By: Relevance
“…As an extensively used and relatively safe drug (6), NAC may be a useful adjuvant for the protection of the myocardium in cardiac surgery, for example as an additive to the cardioplegic solutions. Therefore, given the role of the vascular endothelium in the control of vascular function and its ability to attenuate ischemia-reperfusion-related injuries to the myocardium (7), the present study was carried out in order to determine the effects of oxidative stress on the vascular reactivity of canine coronary arteries, as well as the protective role of NAC in an in vitro model of oxidative stress (8).…”
Section: Introductionmentioning
confidence: 99%
“…As an extensively used and relatively safe drug (6), NAC may be a useful adjuvant for the protection of the myocardium in cardiac surgery, for example as an additive to the cardioplegic solutions. Therefore, given the role of the vascular endothelium in the control of vascular function and its ability to attenuate ischemia-reperfusion-related injuries to the myocardium (7), the present study was carried out in order to determine the effects of oxidative stress on the vascular reactivity of canine coronary arteries, as well as the protective role of NAC in an in vitro model of oxidative stress (8).…”
Section: Introductionmentioning
confidence: 99%
“…Potentially, this reaction could be anticipated and preempted, or addressed quickly with the administration of an antihistamine, steroids, or epinephrine as needed, an approach advocated previously for the management of anaphylactoid reactions to intravenous NAC. 10 The results presented in this study are encouraging; however, they raise further question as to whether intravenous NAC is beneficial in pediatric patients with non-APAP-induced ALF. It is possible that some of the patients diagnosed as non-APAP-induced ALF may in fact have been APAP-adduct positive, suggesting "subtoxic" exposure to APAP, which would significantly impact disease progression.…”
mentioning
confidence: 63%
“…Hafif yan etkilerde infüzyonun durdurulması ve antihistaminik verilmesi ile semptomlar düzelmektedir. 6,7,12 Olgumuzda da NAC infüzyonunun durdurulması ve intramuskü-ler adrenalin verilmesinden kısa bir süre sonra anafilaksi semptomları gerilemiştir.…”
Section: Olgu Sunumuunclassified